Brain Tumor Pathology

Papers
(The median citation count of Brain Tumor Pathology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Intraspinal ASPSCR1::TFE3 rearranged tumor with nerve differentiation23
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recu20
Double-hit primary central nervous system lymphoma with histogenetically proven bone marrow infiltration: a case report and a review of the literature15
Preface for Brain Tumor Pathology vol.41 issue 215
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma14
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma12
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis12
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next11
Targeting TGF-β signaling in glioblastoma: therapeutic implications and novel drug development strategies10
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment9
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lym8
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation7
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next7
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors6
Three-dimensional visualization of human brain tumors using the CUBIC technique6
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas5
Biphasic high-grade cerebellar glioma with epithelial-like components: challenges in integrated diagnosis imposed by limited sampling5
Exploratory analysis of miRNAs-21, -26a, -34a, -181c, -181d, and -485-5p as potential biomarkers for tumor treating fields sensitivity in primary glioblastoma cell cultures5
Gyriform infiltration indicates tumor invasion burden of isocitrate dehydrogenase 1/2-wildtype gliomas5
Tectal glioma: clinical, radiological, and pathological features, and the importance of molecular analysis4
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report4
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma4
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas4
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report4
Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment4
Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant4
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis4
Triple sellar collision lesion: a unique case of pituitary adenoma, Rathke cleft cyst, and xanthogranuloma—case report and systematic review of the literature4
Meningioma with trabecular architecture: a harbinger of BAP1 deficiency4
Rare intracranial mesenchymal tumors with FET::CREB fusions: clinicopathologic spectrum of four cases with integrated molecular analysis and review of the literature4
Diverse NF2 alterations in cranial schwannomas: a two-case series of germline whole-gene deletion and somatic in-frame deletion4
Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations associated with4
Activated astrocytes drive the accumulation of apolipoprotein E at the brain tumor edge3
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment3
Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence3
Utility of digital PCR for detecting TERT promoter mutations and CDKN2A homozygous deletion in meningioma3
Histopathological evaluation of dopamine receptor D2 expression in symptomatic gonadotroph pituitary neuroendocrine tumors: a case series including a rare metastatic case responsive to a dopamine agon3
Reappraisal of novel molecular parameters for meningioma grading by cIMPACT-NOW update 8 proposals3
Astroblastoma with MN1::BEND2 in an elderly patient: A case report and review of the literature3
Progression of long-term “untreated” oligodendroglioma cases: possible contribution of genomic instability3
A case of primary papillary epithelial tumor of the sella with reverse polarity and paired box 8 expression3
Comprehensive molecular characterization of craniopharyngiomas using whole transcriptome and spatial transcriptomics approaches2
Histologically indolent but widely disseminated diffuse midline glioma H3K27-altered revealed by autopsy2
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL2
Tectal glioma with pilocytic astrocytoma morphology carrying a histone H3 K27M mutation and malignant transformation: a literature review2
Aggressive nonfunctioning pituitary neuroendocrine tumors2
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology2
An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive2
How is rosette formation in brain tumours linked with cerebrospinal fluid spread?2
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature1
Correction: Comparative molecular profiles of distinct tumor components in recurrent tentorial meningioma after stereotactic radiosurgery: a case report implicating acquired aggressive alterations ass1
Feasibility of long-read nanopore sequencing for methylation-based classification of posterior fossa ependymomas1
CDKN2A/B status and histological grade independently predict post-recurrence survival in recurrent IDH-mutant astrocytoma1
Emergence of NEC features in corticotroph PitNETs: primary tumor, radiation-induced transformation, or metastasis?1
Multifocal rosette-forming glioneuronal tumor-like low-grade glioneuronal tumor with dysembryoplastic neuroepithelial tumor features associated with drug-resistant epilepsy: a case report and literatu1
PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report1
Liquid biomarkers in glioma1
Visualizing the endothelial glycocalyx in human glioma vasculature1
MAPK pathway alterations in polymorphous low-grade neuroepithelial tumor of the young: diagnostic considerations1
0.059988975524902